1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
van Dongen, M.J.P.
Cederberg, A.
Carlsson, P.
Enerback, S.
Wikstrom, M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
296
351
359
10.1006/jmbi.1999.3476
10669593
Solution structure and dynamics of the DNA-binding domain of the adipocyte-transcription factor FREAC-11.
2000
10.2210/pdb1d5v/pdb
pdb_00001d5v
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
11083.717
S12 TRANSCRIPTION FACTOR (FKH-14)
DNA-BINDING DOMAIN
1
man
polymer
no
no
MLVKPPYSYIALITMAIQNAPEKKITLNGIYQFIMDRFPFYRENKQGWQNSIRHNLSLNECFVKVPRDDKKPGKGSYWTL
DPDSYNMFENGSFL
MLVKPPYSYIALITMAIQNAPEKKITLNGIYQFIMDRFPFYRENKQGWQNSIRHNLSLNECFVKVPRDDKKPGKGSYWTL
DPDSYNMFENGSFL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
ADIPOSE TISSUE
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
PLASMID
PET-11A
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-10-11
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
RCSB
Y
RCSB
1999-10-12
REL
REL
HNCA, HN(CO)CA, HNCACB, CACB(CO)NH AND HNCO EXPERIMENTS WERE USED TO OBTAIN SEQUENTIAL ASSIGNMENTS FOR THE BACKBONE. SIDE-CHAIN RESONANCES WERE ASSIGNED USING TOCSY-15N-HSQC, C(CO)NH, H(CCO)NH AND HC(C)H-TOCSY EXPERIMENTS.
structures with the lowest energy
125
25
3D_15N-SEPARATED_NOESY
3D_13C-SEPARATED_NOESY
HNHA
CROSS RELAXATION BETWEEN 13CA-1HA DIPOLAR AND 13C' CHEMICAL SHIFT ANISOTROPY
CROSS RELAXATION BETWEEN 13CA-1HA AND 15N-1HN DIPOLAR INTERACTIONS
15 mM
6.1
AMBIENT
300
K
THE STRUCTURE WAS DETERMINED FROM 1042 DISTANCE RESTRAINTS, COMPLEMENTED WITH 145 RESTRAINTS ON DIHEDRAL ANGLES AND 36 RESTRAINTS ON HYDROGEN BOND LENGTHS.
COMBINED DISTANCE GEOMETRY/SIMULATING ANNEALING PROCEDURE
8
closest to the average
1 MM S12 DBD, 10 MM NACL, 5 MM MGCL2, 0.02% NAN3, 5 MM DTT
1 MM S12 DBD, 10 MM NACL, 5 MM MGCL2, 0.02% NAN3, 5 MM DTT
DELAGLIO
refinement
NMRPipe
1
KRAULIS
refinement
ANSIG
3.3
BRUNGER
structure solution
X-PLOR
3.1
800
Varian
UNITYPLUS
600
Varian
UNITYPLUS
500
Varian
UNITYPLUS
MET
1
n
1
MET
1
A
LEU
2
n
2
LEU
2
A
VAL
3
n
3
VAL
3
A
LYS
4
n
4
LYS
4
A
PRO
5
n
5
PRO
5
A
PRO
6
n
6
PRO
6
A
TYR
7
n
7
TYR
7
A
SER
8
n
8
SER
8
A
TYR
9
n
9
TYR
9
A
ILE
10
n
10
ILE
10
A
ALA
11
n
11
ALA
11
A
LEU
12
n
12
LEU
12
A
ILE
13
n
13
ILE
13
A
THR
14
n
14
THR
14
A
MET
15
n
15
MET
15
A
ALA
16
n
16
ALA
16
A
ILE
17
n
17
ILE
17
A
GLN
18
n
18
GLN
18
A
ASN
19
n
19
ASN
19
A
ALA
20
n
20
ALA
20
A
PRO
21
n
21
PRO
21
A
GLU
22
n
22
GLU
22
A
LYS
23
n
23
LYS
23
A
LYS
24
n
24
LYS
24
A
ILE
25
n
25
ILE
25
A
THR
26
n
26
THR
26
A
LEU
27
n
27
LEU
27
A
ASN
28
n
28
ASN
28
A
GLY
29
n
29
GLY
29
A
ILE
30
n
30
ILE
30
A
TYR
31
n
31
TYR
31
A
GLN
32
n
32
GLN
32
A
PHE
33
n
33
PHE
33
A
ILE
34
n
34
ILE
34
A
MET
35
n
35
MET
35
A
ASP
36
n
36
ASP
36
A
ARG
37
n
37
ARG
37
A
PHE
38
n
38
PHE
38
A
PRO
39
n
39
PRO
39
A
PHE
40
n
40
PHE
40
A
TYR
41
n
41
TYR
41
A
ARG
42
n
42
ARG
42
A
GLU
43
n
43
GLU
43
A
ASN
44
n
44
ASN
44
A
LYS
45
n
45
LYS
45
A
GLN
46
n
46
GLN
46
A
GLY
47
n
47
GLY
47
A
TRP
48
n
48
TRP
48
A
GLN
49
n
49
GLN
49
A
ASN
50
n
50
ASN
50
A
SER
51
n
51
SER
51
A
ILE
52
n
52
ILE
52
A
ARG
53
n
53
ARG
53
A
HIS
54
n
54
HIS
54
A
ASN
55
n
55
ASN
55
A
LEU
56
n
56
LEU
56
A
SER
57
n
57
SER
57
A
LEU
58
n
58
LEU
58
A
ASN
59
n
59
ASN
59
A
GLU
60
n
60
GLU
60
A
CYS
61
n
61
CYS
61
A
PHE
62
n
62
PHE
62
A
VAL
63
n
63
VAL
63
A
LYS
64
n
64
LYS
64
A
VAL
65
n
65
VAL
65
A
PRO
66
n
66
PRO
66
A
ARG
67
n
67
ARG
67
A
ASP
68
n
68
ASP
68
A
ASP
69
n
69
ASP
69
A
LYS
70
n
70
LYS
70
A
LYS
71
n
71
LYS
71
A
PRO
72
n
72
PRO
72
A
GLY
73
n
73
GLY
73
A
LYS
74
n
74
LYS
74
A
GLY
75
n
75
GLY
75
A
SER
76
n
76
SER
76
A
TYR
77
n
77
TYR
77
A
TRP
78
n
78
TRP
78
A
THR
79
n
79
THR
79
A
LEU
80
n
80
LEU
80
A
ASP
81
n
81
ASP
81
A
PRO
82
n
82
PRO
82
A
ASP
83
n
83
ASP
83
A
SER
84
n
84
SER
84
A
TYR
85
n
85
TYR
85
A
ASN
86
n
86
ASN
86
A
MET
87
n
87
MET
87
A
PHE
88
n
88
PHE
88
A
GLU
89
n
89
GLU
89
A
ASN
90
n
90
ASN
90
A
GLY
91
n
91
GLY
91
A
SER
92
n
92
SER
92
A
PHE
93
n
93
PHE
93
A
LEU
94
n
94
LEU
94
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
VAL
63
A
N
VAL
63
A
O
THR
79
A
O
THR
79
2
A
A
HG1
H
THR
LEU
79
80
1.34
2
A
A
HH
O
TYR
GLN
31
49
1.53
3
A
A
H
O
VAL
TYR
65
77
1.51
3
A
A
O
HD21
MET
ASN
15
19
1.57
3
A
A
O
HE1
ASN
TRP
44
48
1.58
3
A
A
O
H
ILE
THR
10
14
1.59
5
A
A
HH
H
TYR
ARG
31
53
1.26
5
A
A
O
H
ASN
SER
55
57
1.50
5
A
A
HH21
O
ARG
LYS
67
74
1.57
6
A
A
HH
O
TYR
GLN
31
49
1.44
7
A
A
OD1
H
ASP
ASP
68
69
1.60
8
A
A
HH
O
TYR
GLN
31
49
1.56
8
A
A
O
HD1
ASN
HIS
50
54
1.56
9
A
A
HD22
HD22
ASN
ASN
55
59
1.26
9
A
A
HE
O
ARG
LYS
67
74
1.50
10
A
A
HH
HE
TYR
ARG
31
53
1.27
10
A
A
OD1
H
ASP
ASP
68
69
1.52
11
A
A
OD1
HH12
ASN
ARG
19
37
1.55
12
A
A
HH11
H
ARG
LYS
67
74
1.23
12
A
A
HH12
HZ1
ARG
LYS
67
71
1.32
12
A
A
O
H
PRO
SER
82
84
1.50
17
A
A
HH
O
TYR
GLN
31
49
1.50
18
A
A
O
H
ASN
SER
90
92
1.49
19
A
A
HG
H
SER
ALA
8
11
1.34
19
A
A
O
H
ASP
LYS
69
71
1.59
20
A
A
HD22
HD22
ASN
ASN
55
59
1.29
20
A
A
HH
O
TYR
GLN
31
49
1.40
22
A
A
O
H
GLY
SER
47
51
1.50
22
A
A
O
H
ASP
TYR
83
85
1.59
23
A
A
HH
O
TYR
GLN
31
49
1.59
24
A
A
HG1
H
THR
GLY
26
29
1.34
24
A
A
O
HE1
ASN
TRP
44
48
1.57
1
A
PRO
6
-48.41
-8.03
1
A
LEU
56
-69.59
59.00
1
A
SER
57
-172.55
-55.64
1
A
ARG
67
-72.23
-168.58
1
A
PRO
72
-82.18
-157.78
1
A
SER
84
-83.54
49.03
1
A
MET
87
-69.05
6.15
2
A
PRO
5
-42.66
155.57
2
A
PRO
82
-50.86
-137.16
3
A
PRO
5
-45.58
160.57
3
A
PRO
39
-49.75
-7.25
3
A
GLN
46
-59.91
-168.89
3
A
LYS
74
-82.94
-105.99
3
A
PRO
82
-55.12
-141.86
3
A
ASP
83
-81.96
45.38
3
A
PHE
93
-46.46
-13.76
4
A
PRO
6
-73.27
28.79
4
A
ARG
67
-79.07
-161.38
5
A
PRO
6
-42.25
-12.11
5
A
PRO
39
-50.31
-6.07
5
A
LEU
56
-65.29
59.21
5
A
SER
57
-159.97
-54.87
5
A
PRO
66
-71.12
-168.84
5
A
PRO
82
-53.25
-79.72
5
A
ASP
83
-162.08
42.62
5
A
SER
84
-45.37
110.00
5
A
TYR
85
-89.95
-76.67
5
A
ASN
90
-80.96
44.68
6
A
PRO
6
-74.67
27.66
6
A
PRO
82
-49.69
-135.99
6
A
SER
84
-179.97
44.30
6
A
PHE
88
-89.49
35.87
6
A
ASN
90
-65.96
1.50
6
A
SER
92
-173.47
120.36
7
A
PRO
5
-40.93
154.26
7
A
PRO
6
-75.72
30.22
7
A
PRO
21
-37.33
-73.94
7
A
GLU
22
-90.10
-79.97
7
A
LYS
23
-165.50
-34.65
7
A
LYS
45
-95.55
-66.39
7
A
PRO
66
-35.52
162.67
7
A
ARG
67
-59.79
-172.36
7
A
PRO
72
-47.89
-131.68
8
A
PRO
6
-73.40
26.61
8
A
PRO
82
-74.55
-153.69
8
A
SER
84
-59.30
85.83
8
A
PHE
88
-59.15
-107.82
8
A
ASN
90
-90.89
31.35
9
A
PRO
6
-42.03
-12.17
9
A
LYS
70
-49.82
-15.21
9
A
ASP
81
-50.84
177.97
9
A
PRO
82
-60.87
-145.10
9
A
TYR
85
-90.04
-79.41
9
A
SER
92
-102.87
-159.60
10
A
PRO
6
-74.17
20.93
10
A
PRO
39
-49.03
-9.85
10
A
LYS
45
-90.41
-78.65
10
A
PRO
66
-74.45
-154.26
11
A
PRO
5
-44.59
150.26
11
A
PRO
39
-45.76
-7.42
11
A
GLN
46
-59.07
-118.08
11
A
PRO
82
-48.31
-72.15
11
A
ASP
83
-157.72
39.77
11
A
SER
84
-50.13
89.00
11
A
ASN
86
-150.22
29.61
12
A
LYS
45
-94.59
-68.33
12
A
PRO
66
-45.46
175.90
12
A
PRO
82
-66.82
-154.84
12
A
ASP
83
-67.69
52.60
13
A
PRO
39
-52.11
-3.93
13
A
ASN
44
-111.19
77.27
13
A
ARG
67
-69.39
-107.53
13
A
PRO
72
-41.59
163.75
13
A
PRO
82
-79.18
-162.46
13
A
ASP
83
-83.35
45.80
13
A
PHE
88
-150.03
-139.07
14
A
PRO
66
-78.16
-169.49
14
A
LEU
80
-103.96
65.65
14
A
ASP
81
-152.72
83.50
14
A
PRO
82
-57.06
-77.30
14
A
ASP
83
-155.64
41.56
15
A
PRO
6
-39.79
-23.36
15
A
PRO
66
-79.41
-155.87
15
A
PRO
82
-59.83
-136.75
15
A
SER
84
-81.53
37.78
15
A
MET
87
-47.49
173.19
15
A
SER
92
-160.38
114.20
16
A
PRO
5
-42.52
158.31
16
A
GLN
46
-70.43
-160.18
16
A
ASP
81
-49.98
173.06
16
A
PRO
82
-66.51
-146.13
16
A
SER
84
-47.08
99.45
16
A
TYR
85
-79.93
-70.04
16
A
SER
92
-145.19
-39.65
17
A
PRO
6
-45.11
-8.33
17
A
ASP
81
-46.73
167.44
17
A
PRO
82
-53.98
-145.24
17
A
SER
84
1.95
61.75
17
A
GLU
89
-57.41
-9.59
18
A
PRO
82
-60.87
-141.35
18
A
ASP
83
-93.08
31.79
18
A
SER
84
-49.57
87.48
18
A
ASN
86
-146.52
24.11
18
A
ASN
90
-44.16
166.36
18
A
PHE
93
-55.57
172.03
19
A
LYS
4
-45.98
107.68
19
A
PRO
21
-33.60
-84.37
19
A
GLU
22
-90.02
-80.05
19
A
LYS
23
-159.16
-33.69
19
A
PRO
39
-48.45
-6.87
19
A
GLN
46
-47.39
-177.95
19
A
PRO
66
-45.10
151.09
19
A
LYS
70
-70.35
47.42
19
A
ASP
81
-48.56
176.68
19
A
PRO
82
-66.58
-142.35
19
A
SER
84
-54.96
83.43
20
A
PRO
6
-39.64
-17.99
20
A
PRO
66
-43.63
160.63
20
A
PRO
72
-54.83
-145.32
20
A
ASP
81
-53.56
174.33
20
A
PRO
82
-62.54
-140.07
20
A
SER
84
-58.09
75.58
20
A
ASN
86
-154.03
82.31
21
A
PRO
6
-39.74
-24.36
21
A
LEU
80
-74.98
-133.81
21
A
PRO
82
-75.17
-145.75
21
A
SER
84
-50.48
-7.58
21
A
MET
87
-60.70
-155.77
21
A
PHE
88
-70.39
-149.95
22
A
PRO
21
-38.79
-28.12
22
A
PRO
39
-46.68
-7.22
22
A
GLN
46
-48.24
177.80
22
A
PRO
72
-64.71
13.72
22
A
ASP
81
-49.24
175.73
22
A
PRO
82
-64.88
-143.51
22
A
ASP
83
-95.49
32.03
22
A
SER
84
-63.47
67.88
22
A
GLU
89
-77.32
-160.71
23
A
PRO
66
-42.87
167.61
23
A
PRO
82
-83.76
-152.73
23
A
MET
87
-48.11
175.15
24
A
LYS
24
-79.86
33.13
24
A
GLN
46
-61.18
-169.18
24
A
PRO
66
-44.63
177.57
24
A
PRO
72
-43.96
-10.62
24
A
ASP
81
-171.71
73.76
24
A
PRO
82
-60.91
-143.33
24
A
ASP
83
-88.62
44.59
24
A
SER
84
-62.62
71.43
24
A
ASN
86
-140.44
31.10
25
A
PRO
39
-45.72
-9.44
25
A
PRO
72
-73.25
-166.82
25
A
LEU
80
-59.69
-121.24
25
A
PRO
82
-52.40
-130.11
25
A
PHE
88
-62.20
-136.89
SOLUTION STRUCTURE OF THE FORKHEAD DOMAIN OF THE ADIPOCYTE-TRANSCRIPTION FACTOR FREAC-11 (S12)
1
N
N
A
SER
8
A
SER
8
HELX_P
A
ASN
19
A
ASN
19
1
1
12
A
THR
26
A
THR
26
HELX_P
A
PHE
38
A
PHE
38
1
2
13
A
PRO
39
A
PRO
39
HELX_P
A
ASN
44
A
ASN
44
1
3
6
A
GLY
47
A
GLY
47
HELX_P
A
ASN
59
A
ASN
59
1
4
13
GENE REGULATION
WINGED HELIX, DNA-RECOGNITION HELIX, GENE REGULATION
FOXC2_HUMAN
UNP
1
Q99958
69
162
1D5V
1
94
Q99958
A
1
1
94
1
ASP
conflict
MET
1
1D5V
A
Q99958
UNP
69
1
2
anti-parallel
A
PHE
62
A
PHE
62
A
LYS
64
A
LYS
64
A
TRP
78
A
TRP
78
A
LEU
80
A
LEU
80
1
P 1